In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved.
Several specialties, traditionally believed to be mainstays of the hospital setting, are moving significantly toward ASCs, according to L.E.K. Consulting’s “2024 ASC Insights Study.”
United Surgical Partners International, SCA Health and AmSurg are among the largest ASC chains. Here is how the companies stack up based on the number of ASCs in their networks and affiliated physicians.